Gray scale ultrasound imaging. The anatomy and pathology of the liver.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMID 1265273)

Published in Radiology on May 01, 1976

Authors

K J Taylor, D A Carpenter, C R Hill, V R McCready

Articles by these authors

Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA (1998) 4.76

Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics (1994) 3.74

WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci U S A (2001) 2.79

Dose-repetition increases the mutagenic effectiveness of N-ethyl-N-nitrosourea in mouse spermatogonia. Proc Natl Acad Sci U S A (1985) 2.22

Ultrasonically induced cavitation in vivo. Br J Cancer Suppl (1982) 2.14

Ectopic pregnancy: evaluation with endovaginal color flow imaging. Radiology (1992) 2.10

Blood flow in deep abdominal and pelvic vessels: ultrasonic pulsed-Doppler analysis. Radiology (1985) 2.06

Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer (1983) 1.73

Grey scale echography in the diagnosis of intrahepatic disease. J Clin Ultrasound (1973) 1.71

Ultrasound and scintigraphy in the differential diagnosis of obstructive jaundice. J Clin Ultrasound (1974) 1.70

Effects of ENU dosage on mouse strains. Mamm Genome (2000) 1.69

Lower extremity volumetric arterial blood flow in normal subjects. Ultrasound Med Biol (1998) 1.69

Acute focal bacterial nephritis (acute lobar nephronia). Radiology (1979) 1.64

Ultrasonic attenuation and propagation speed in mammalian tissues as a function of temperature. Ultrasound Med Biol (1979) 1.64

A strategy for fine-structure functional analysis of a 6- to 11-centimorgan region of mouse chromosome 7 by high-efficiency mutagenesis. Proc Natl Acad Sci U S A (1990) 1.59

FDG accumulation and tumor biology. Nucl Med Biol (1998) 1.59

Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N Engl J Med (1990) 1.54

The potential of intratumoural unsealed radioactive source therapy. Eur J Nucl Med (2001) 1.49

N-ethyl-N-nitrosourea mutagenesis of a 6- to 11-cM subregion of the Fah-Hbb interval of mouse chromosome 7: Completed testing of 4557 gametes and deletion mapping and complementation analysis of 31 mutations. Genetics (1999) 1.46

Future directions for unsealed source radionuclide therapy for bone metastases. Eur J Nucl Med Mol Imaging (2002) 1.45

Timing, magnitude, and utility of surgical delay in the TRAM flap: II. Clinical studies. Plast Reconstr Surg (1997) 1.44

Physical test for distant metastases in patients with breast cancer. J R Soc Med (1980) 1.42

Assessment tools for the identification of patients at risk for the development of pressure sores: a review. J Enterostomal Ther (1988) 1.41

A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D. Cancer Res (2000) 1.39

Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial. J Pediatr (1994) 1.38

Ultrasonic irradiation of mammalian cells in vitro at hyperthermic temperatures. Br J Radiol (1980) 1.36

Intraventricular hemorrhage in the preterm neonate: timing and cerebral blood flow changes. J Pediatr (1984) 1.35

N-ethyl-N-nitrosourea-induced prenatally lethal mutations define at least two complementation groups within the embryonic ectoderm development (eed) locus in mouse chromosome 7. Mamm Genome (1993) 1.29

Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1. Proc Natl Acad Sci U S A (2001) 1.28

Effect of dose fractionation on the ethylnitrosourea induction of specific-locus mutations in mouse spermatogonia. Proc Natl Acad Sci U S A (1982) 1.28

Calibration of ultrasonic beams for bio-medical applications. Phys Med Biol (1970) 1.27

31P-NMR studies of a human tumour in situ. Lancet (1983) 1.27

Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment. NMR Biomed (1998) 1.27

The role of cavitation in the interaction of ultrasound with V79 Chinese hamster cells in vitro. Br J Cancer Suppl (1982) 1.26

Transvaginal ultrasonography for the diagnosis of ectopic pregnancy. Fertil Steril (1988) 1.26

Grey-scale ultrasonography in the differential diagnosis of jaundice. Arch Surg (1977) 1.25

Artifacts in ultrasound imaging. J Ultrasound Med (1986) 1.22

Scrotal masses with a uniformly hyperechoic pattern. Radiology (1983) 1.21

Grey-scale ultrasonography for monitoring industrial exposure to hepatotoxic agents. Lancet (1975) 1.21

Measurement of soft tissue motion using correlation between A-scans. Ultrasound Med Biol (1982) 1.21

Compensatory mechanisms for chronic cerebral hypoperfusion in patients with carotid occlusion. Stroke (1999) 1.18

In-vivo 31P magnetic resonance spectroscopy for monitoring treatment response in breast cancer. Lancet (1989) 1.18

Direct evidence of cavitation in vivo from diagnostic ultrasound. Ultrasound Med Biol (1996) 1.16

The use of angular acoustic scattering measurements to estimate structural parameters of human and animal tissues. J Acoust Soc Am (1986) 1.16

Clinical radioisotope scanning. Br J Radiol (1967) 1.16

Distinct expression patterns of notch family receptors and ligands during development of the mammalian inner ear. Mech Dev (1998) 1.13

CT and sonography in the recognition of mucocele of the appendix. AJR Am J Roentgenol (1984) 1.13

Accuracy of grey-scale ultrasound diagnosis of abdominal and pelvic abscesses in 220 patients. Lancet (1978) 1.13

Ultrasonography of alcoholic liver disease with histological correlation. Radiology (1981) 1.13

Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-111. Lancet (1983) 1.12

False positive 131I whole body scans in thyroid cancer. Br J Radiol (2000) 1.11

Observer variability in echo-Doppler measurements of portal flow in cirrhotic patients and normal volunteers. Gastroenterology (1990) 1.11

Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. Br J Radiol (1984) 1.10

Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress. Radiology (1996) 1.09

A co-ordinate transfer system for the Pho Gamma 3 Nuclear Chicago gamma camera. Br J Radiol (1969) 1.09

Surgical and pathologic correlation of cholecystosonography and cholecystography. AJR Am J Roentgenol (1978) 1.08

Mechanics of the guinea pig colea. J Acoust Soc Am (1970) 1.07

Congenital absence of the portal vein in oculoauriculovertebral dysplasia (Goldenhar syndrome). Pediatr Radiol (1986) 1.07

Hematopoietic deficiencies in c-mpl and TPO knockout mice. Stem Cells (1998) 1.06

Risk factors for early intraventricular hemorrhage in low birth weight infants. J Pediatr (1992) 1.05

A low-molecular-weight angiogenic factor in cat retina. Br J Ophthalmol (1982) 1.05

Histological changes in rat liver tumours treated with high-intensity focused ultrasound. Ultrasound Med Biol (1993) 1.04

Gray scale ultrasound and isotope scanning: complementary techniques for imaging the liver. AJR Am J Roentgenol (1977) 1.03

Iodine kinetic studies during amiodarone treatment. J Clin Endocrinol Metab (1986) 1.03

Ultrasound Doppler flow studies of the ovarian and uterine arteries. Br J Obstet Gynaecol (1985) 1.02

The prognostic significance of the half-life of serum CA 125 in patients responding to chemotherapy for epithelial ovarian carcinoma. Br J Obstet Gynaecol (1989) 1.01

Increased oxygen extraction fraction is associated with prior ischemic events in patients with carotid occlusion. Stroke (1998) 1.01

Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res (1996) 0.99

Physical and chemical aspects of ultrasonic disruption of cells. J Acoust Soc Am (1970) 0.99

The non-invasive monitoring of low dose, infusional 5-fluorouracil and its modulation by interferon-alpha using in vivo 19F magnetic resonance spectroscopy in patients with colorectal cancer: a pilot study. Ann Oncol (1993) 0.99

Deletion mapping of four loci defined by N-ethyl-N-nitrosourea-induced postimplantation-lethal mutations within the pid-Hbb region of mouse chromosome 7. Genetics (1993) 0.99

Combined pancreas and liver scanning using a double isotope technique. Br J Radiol (1971) 0.98

Radiation dose assessment in radioiodine therapy. 2. Practical implementation using quantitative scanning and PET, with initial results on thyroid carcinoma. Radiother Oncol (1989) 0.98

Pleiotropy in microdeletion syndromes: neurologic and spermatogenic abnormalities in mice homozygous for the p6H deletion are likely due to dysfunction of a single gene. Proc Natl Acad Sci U S A (1995) 0.98

The possibility of hazard in medical and industrial applications of ultrasound. Br J Radiol (1968) 0.98

High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone. Br J Cancer (2002) 0.98

Monitoring liver disorders in vinyl chloride monomer workers using greyscale ultrasonography. Br J Ind Med (1976) 0.97

Correlation of findings on transvaginal sonography with serum CA 125 levels. AJR Am J Roentgenol (1997) 0.97

Hepatic artery pseudoaneurysm: diagnosis with real-time and pulsed Doppler US. Radiology (1986) 0.97

62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases. Eur J Nucl Med (2001) 0.96

Damage to the hippocampal formation in rats selectively impairs the ability to learn cue relationships. Behav Neural Biol (1989) 0.96

The mouse scurfy (sf) mutation is tightly linked to Gata1 and Tfe3 on the proximal X chromosome. Mamm Genome (1994) 0.95

Attenuation of ultrasound in skeletal muscle. Ultrasonics (1979) 0.95

Polonium-210 in man. Nature (1965) 0.95

The use of ultrasound to enhance the diagnostic utility of the equivocal liver scintigraph. Radiology (1978) 0.95

A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism. Br J Cancer (1991) 0.95

The role of ultrasound in the assessment and treatment of abdominal metastases from testicular tumours. Clin Radiol (1977) 0.94

A search for chromosome damage following exposure of Chinese hamster cells to high intensity, pulsed ultrasound. Br J Radiol (1972) 0.94

Phospholipid metabolites, prognosis and proliferation in human breast carcinoma. NMR Biomed (1994) 0.94

A constant depth ultrasonic scanner. Br J Radiol (1971) 0.94

Ultrasonic propagation through fixed and unfixed tissues. Ultrasound Med Biol (1979) 0.94

Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants. J Pediatr (1985) 0.94

In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein-protein complexes in paraffin sections from breast cancer tissues. Br J Cancer (2010) 0.94

The mechanism of accumulation of tumour-localising radiopharmaceuticals. Eur J Nucl Med (1998) 0.93

A study of the production of haemorrhagic injury and paraplegia in rat spinal cord by pulsed ultrasound of low megaHertz frequencies in the context of the safety for clinical usage. Br J Radiol (1972) 0.92